Pentosan Polysulfate Sodium News
Pentosan Polysulfate Sodium currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Pentosan Polysulfate Sodium with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Elmiron is indicated for the treatment of bladder pain syndrome characterized by either glomerulations or Hunner’s lesions in adults with moderate to severe pain, urgency and frequency of micturition.
- Evidence level: L5
- Predicted indications (20):
- primary release disorder of platelets (99.7%)
- Glanzmann thrombasthenia (99.7%)
- pseudo-von Willebrand disease (99.6%)
- heparin-induced thrombocytopenia (disease) (98.8%)
- fetal and neonatal alloimmune thrombocytopenia (98.7%)
- autosomal dominant macrothrombocytopenia (97.8%)
- hemoglobinopathy (97.7%)
- autoimmune hemolytic anemia (97.7%)
- autoimmune thrombocytopenic (97.6%)
- bleeding diathesis due to a collagen receptor defect (97.5%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (97.5%)
- rheumatoid arthritis (97.3%)
- platelet-type bleeding disorder (97.2%)
- acquired aplastic anemia (97.0%)
- partial deletion of the short arm of chromosome 16 (96.8%)
- penile fibromatosis (96.7%)
- disorder of GPI anchor biosynthesis (96.7%)
- beta-thalassemia with other manifestations (96.6%)
- bone Paget disease (96.6%)
- hemolytic anemia due to glucophosphate isomerase deficiency (96.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.